Phase 3 ALTO trial designed to demonstrate superiority of KSI-501 versus aflibercept in patients wit

Phase 3 ALTO trial designed to demonstrate superiority of KSI-501 versus aflibercept in patients wit

First pivotal cohort enrolled 300 subjects, with topline clinical data from 24-week primary endpoint

JP Morgan analyst Anupam Rama maintains Kodiak Sciences (NASDAQ:KOD) with a Overweight and raises

Shares of Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report) shot up 6.6% on Friday. The company t

Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected f

Kodiak Sciences (KOD) is transitioning from past clinical disappointments to a maturing retina platf

This clinical-stage biotech focused on retinal therapies reported a notable insider sale amid a year

KOD surges on positive phase III Zenkuda data, accelerated regulatory plans, advancing late-stage pr

PALO ALTO, Calif., May 28, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial

This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate a

KOD posts a wider Q1 loss as research & development spending rises, while positive phase III Zenkuda

PALO ALTO, Calif., May 7, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported re

Clinical results of KSI-101 in macular edema secondary to inflammation (MESI) from a tertiary care u

Kodiak Sciences (KOD) reported earnings 30 days ago. What's next for the stock?

The small-cap Russell 2000 punched through to an intraday record high on Friday, capping a furious 1

KOD posts wider Q4 loss. However, its pipeline advances, with strong phase III data for Zenkuda driv

U.S. stocks rise, Dow Jones up 400+ points. PVH Corp beats expectations, shares jump 9.9%. Other big

PALO ALTO, Calif., March 31, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported

Kodiak Sciences' stock (NASDAQ: KOD) experienced a substantial 62% surge last week, elevating the st

Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report) shares hit a new 52-week high during trading on

Kodiak Sciences rallies 75% as phase III GLOW2 data show Zenkuda's strong efficacy, safety and risk

Investors appear to be responding to both the strength of the data and the possibility of a faster p

U.S. stocks lower, Nasdaq falls 1%. Oxford Industries up 11.2% on strong earnings, raised dividend.

Olaplex Holdings shares surge 51% after being acquired by Henkel AG & Co. KGaA. Other big gainer

Shares of drug developer Kodiak Sciences jumped 52% before the bell on Thursday after its experiment

Building on the success of GLOW1 and with all patients on a 6-month dosing interval, Zenkuda (tarcoc

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quart

The Benzinga Stock Whisper Index uses proprietary data to look at stocks with increased interest fro

Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that i

  On Tuesday, 647 companies set new 52-week lows.

  On Monday, 369 companies set new 52-week lows.

  During Thursday's session, 406 companies made new 52-week lows.

  Friday's session saw 225 companies set new 52-week lows.

  On Thursday, 283 companies set new 52-week lows.

Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average vo

U.S. stocks traded higher, with the Dow Jones gaining over 400 points on Friday. Here are some big s